A novel quantitative method for assessing the therapeutic response to Tafamidis therapy in patients with cardiac TTR amyloidosis. A preliminary report.
Title | A novel quantitative method for assessing the therapeutic response to Tafamidis therapy in patients with cardiac TTR amyloidosis. A preliminary report. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Doumas, A., Zegkos T., Parcharidou D., Gossios T., Ntelios D., Chatzileontiadou S., Papanastasiou E., Hatjiharissi E., Iakovou I., & Efthimiadis G. K. |
Journal | Hell J Nucl Med |
Volume | 25 |
Issue | 2 |
Pagination | 216-219 |
Date Published | 2022 May-Aug |
ISSN | 1790-5427 |
Keywords | Aged, Amyloid Neuropathies, Familial, Benzoxazoles, Humans, Male, Radionuclide Imaging, Technetium |
Abstract | OBJECTIVE: Cardiomyopathy is a common manifestation of transthyretin amyloidosis (ATTR), leading to heart failure, associated with high morbidity and mortality. The aim of this study was to investigate the effect of Tafamidis treatment by means of cardiac radiotracer uptake on myocardial scintigraphy. |
DOI | 10.1967/s002449912483 |
Alternate Journal | Hell J Nucl Med |
PubMed ID | 35913870 |